NARI - Rasio utang marang kapitalisasi buku Inari Medical Inc

Logo korporat perusahaan Inari Medical, Inc. (NARI)

Inari Medical, Inc. (NARI) generates revenue from the supply of FlowTriever and ClotTriever systems for mechanical thrombectomy. Its primary customers are radiologists and clinics that utilize catheters for safe vascular treatment. The history of the total debt-to-equity ratio demonstrates financial stability, with the value maintained at 0.08. However, competitive pressure and pricing demands from hospital networks remain key risk factors.

Inari Medical, Inc. - Utang-utang marang kapitalisasi buku NARI (periode 04.07.2022 - 01.03.2025)
Barang unggulan Inari Medical Corp

Inari Medical, Inc. (NARI) demonstrates high financial resilience driven by stable demand for venous procedure systems. The debt-to-book capitalization ratio measures the proportion of borrowed capital relative to equity, determining the level of financial leverage. A decrease in this metric indicates a minimization of credit risks and independence from external loans. Predictable cash flows allow the company to effectively optimize its liability structure. Such a strategy strengthens the fundamental margin of safety and supports the long-term stability of share prices.

Pesaing Inari Medical, Inc.

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|TCMD - Utang marang modal buku|SANUWAVE - Utang-utang marang kapitalisasi buku|Outset Medical Inc (OM) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ELMD|Utang marang nilai buku LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Utang marang nilai buku|Rasio utang marang aset resik PROF (profoundmedical.com)|Baird Medical - Rasio utang marang kapitalisasi buku|Utang marang nilai buku EDAP TMS SA EDAP|APYX (Bovie Medical) - Utang-utang marang kapitalisasi buku|ICCM - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku pulmonx.com|TELA Bio (TELA) - Rasio utang marang nilai buku|CTSO: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Sensus Healthcare Inc|Utang-utang marang kapitalisasi buku ZYXI (Zynex Inc)|Utang marang nilai buku electrocore.com (ECOR)|Utang-utang marang kapitalisasi buku RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Utang-utang marang kapitalisasi buku|ICU - Rasio utang marang kapitalisasi buku|IRIDEX Corporation (IRIX) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku ibs.inc INBS|Beyond Air (XAIR) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku PFSA (Profusa Inc)|Utang-utang marang nilai buku SSKN|GCTK: Rasio utang marang kapitalisasi buku|Utang marang aset resik NanoVibronix Inc. NAOV|Utang marang nilai buku VERO (Venus Concept Corp)|Utang-utang marang kapitalisasi buku Nuwellis Corp NUWE|Utang-utang marang kapitalisasi buku AEMD (Aethlon Medical)|ASXC: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Avinger (AVGR)|BSGM (biosig.com) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CUTR|Utang marang nilai buku Know Labs Corporation|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku